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LAY ABSTRACT
The sickest patients in a hospital often need treatment 
in an intensive care unit. When these patients eventu-
ally go home they often experience continuing psycho-
logical and physical problems, including pain. The aim 
of this study was to look at how often pain occurred in 
this group of patients, where the pain occurred, and if 
the pain was interfering with patient’s lives. We studied 
47 patients after discharge from hospital and found that 
two-thirds of them had pain that they did not have be-
fore their stay in the intensive care unit. We followed up 
these patients over a 1-year period and found that the 
level of pain they experienced did not change over time. 
However, it did not interfere with their lives as much. 
Further studies are needed to find out why pain is such 
a major problem for intensive care unit survivors.
Background: Intensive care unit survivors expe-
rience significant physical and psychological pro-
blems, including chronic pain following discharge. 
The aim of this study was to observe the incidence, 
anatomical sites, intensity, and interference of chro-
nic pain in intensive care unit survivors over a 1-year 
period. In addition, potential predictors of chronic 
pain were analysed. 
Methods: Data were collected during an intensive 
care unit follow-up programme as part of a quality 
improvement initiative. Data from the Brief Pain In-
ventory and from musculoskeletal assessment were 
examined, alongside demographic data from the pa-
tient. Data were collected from patients at baseline 
and at a 1-year follow-up appointment. 
Results: Data from 47 intensive care unit survivors 
were included in this study. In 66% (n = 31) of the 
patients a “new” chronic pain  that did not exist be-
fore their stay in the intensive care, was reported. 
Pain intensity in this patient group was “moderate”’ 
and did not improve significantly over the 1-year pe-
riod. Although pain interference with life decreased 
over the study period, it was still the most common 
cause of reduced enjoyment of life and reduced em-
ployment at 1-year follow-up.
Conclusion: Chronic pain is associated with morbidity 
in intensive care unit survivors. Pain interference, but 
not pain intensity, improved significantly in the first 
year after discharge. Further multi-centre research 
is required to elucidate the chronic pain experience.
Key words: intensive care; chronic pain; post-intensive care 
syndrome; rehabilitation.
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The number of patients surviving a critical illness is increasing worldwide (1). With this increasing 
survivorship, there is now a focus on understanding the 
recovery trajectory of patients (2). Evidence has shown 
that almost two-thirds of intensive care unit (ICU) survi-
vors will experience significant physical, psychological, 
cognitive and social problems in the months and years 
following discharge from critical care (3–5). This group 
of signs and symptoms are now commonly referred to 
as “post intensive care syndrome” (PICS) (6). 
An under-reported feature of PICS is chronic pain 
(7), defined as a “continuous, long-term pain of more 
than 12 weeks or after the time that healing would have 
been thought to have occurred in pain after trauma or 
surgery” (8). In the limited research published to date, 
almost three-quarters of ICU patients (73%) reported 
moderate or severe pain 12 months post-discharge 
(3). A further retrospective analysis of ICU patients 
estimated that the incidence of chronic pain in ICU 
survivors was as high as 44%, with the shoulder being 
the most commonly affected joint (9). A variety of risk 
factors for the development of chronic pain have been 
studied, including increasing patient age and severe 
sepsis (9). However, there is limited evidence about the 
intensity of pain and how this affects activities of daily 
living (ADL). Furthermore, there is a lack of evidence 
regarding how pain is treated pharmacologically. 
The aims of this study were to assess the incidence, 
intensity and location of chronic pain; to explore the 
level of its interference in daily life; and examine the 
drugs required for its treatment. In addition, the study 
explored predictors for developing chronic pain in the 
ICU survivor population, and the changing nature of 
such pain over time. 
MATERIAL AND METHODS
Participants
Patients who attended the pilot phase of an ICU recovery 
programme were included in this evaluation. Intensive Care 
Syndrome: Promoting Independence and Return to Employ-
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cist (PMcT) within the InS:PIRE programme. The analgesics 
prescribed were then assessed according to the World Health 
Organization (WHO) pain ladder, a 3-step scale used by clinici-
ans in the management of pain, which was originally developed 
for cancer pain in adults (22). The WHO pain ladder outlines 
the oral administration of pain-relieving drugs if pain occurs. It 
consists of: step 1: non-opioids (aspirin and paracetamol); step 
2: mild opioids (codeine and tramadol); step 3: strong opioids, 
such as morphine. If pain occurs drugs should be prescribed 
in a stepwise order until the patient is free of pain. Additional 
drugs, called “adjuvants”, can also be added.
A number of patient demographics regarding the patient’s 
stay in the ICU were collected from the ICU database. Also 
collected was information about the patient’s socio-economic 
status. The Scottish Index of Multiple Deprivation (SIMD) 
is the Scottish Government’s tool for identifying socio-eco-
nomically deprived neighbourhoods (13). For the purpose of 
this evaluation, the SIMD was split into quintiles; quintile 5 
represents the most affluent area and quintile 1 represents the 
most deprived area. 
Data analysis
Patient demographics were analysed using descriptive statistics 
and presented as numbers and percentages for the categorical 
variables (and medians and interquartile ranges) for the conti-
nuous variables. 
Inferential statistics were explored using Minitab 17.3.1 Sta-
tistical Software (2016) (23). Means, rather than medians, were 
used in the analysis of the BPI pain intensity and interference 
scale, as recommended by the tool developers (14). Therefore, 
paired t-tests were used to compare initial and 1-year pain 
intensity and interference. An unadjusted modelling strategy 
utilizing binary logistic regression was undertaken to assess the 
predictive capacity of a number of variables on the likelihood 
that participants had “new” chronic pain after an ICU stay. 
Percentages were used to represent all other results. 
Ethical considerations
InS:PIRE was a service improvement project utilizing quality 
improvement methodology within the ICU. Ethics approval was 
sought and waived by our hospital research and development 
department. 
RESULTS
Patients
During this pilot study, 89 patients were invited to take 
part in InS:PIRE. Of these, 49 (55%) attended, and a 
final total of 47 patients received the physiotherapy 
assessment. Baseline demographics for the 47 patients 
are shown in Table I. The median age of participants 
was 52 years (interquartile range (IQR) 43–57 years), 
with a median Acute Physiologiy and Chronic Health 
Evaluation (APACHE II) of 23 (IQR 18–27). The 
largest group of patients came from a general medi-
cine background (40%, n = 19), while 26% (n = 12) of 
patients came from general surgery and 11% (n = 5) 
from gastroenterology (Table II). 
ment (InS:PIRE) is a 5-week, post-ICU, multi-disciplinary, 
peer-supported, rehabilitation programme. Patients who had 
been mechanically ventilated for more than 72 h or in high-
dependency care for more than 2 weeks were invited to parti-
cipate in InS:PIRE 6–20 weeks post hospital discharge. People 
who were further along the recovery trajectory, who self-referred 
into InS:PIRE, were also included. Exclusion criteria for the 
programme included: age less than 18 years; patients with 
significant brain injuries; in-patient psychiatric patients; and 
terminally ill patients. Patients were followed up at 12 months 
post programme attendance. All eligible patients admitted to the 
ICU were invited to join the programme. Data were collected 
between September 2014 and June 2015. Complementary data 
from the InS:PIRE programme has been published elsewhere 
(10–12).
Setting
InS:PIRE was undertaken at Glasgow Royal Infirmary (GRI), 
a large tertiary referral teaching hospital in Scotland. It has a 
20-bedded general intensive care/high-dependency unit provi-
ding tertiary care for pancreatic, burn, oesophageal and plastic 
surgery. The hospital serves a community of severe socio-
economic deprivation in the West of Scotland (13). 
Intervention and measures
A musculoskeletal assessment was conducted by the physio-
therapist (HD) during the 5-week programme (i.e. once during 
the 5-week period). Patients were asked during the musculos-
keletal assessment to comment on any “new” pains since their 
admission to ICU, which had been present for more than 12 
weeks. In the present study this was utilized to indicate the 
incidence of pain. The location of the patient’s pain was then 
coded by body site.
To understand the impact of pain following discharge from 
critical care, the Brief Pain Inventory (BPI) outcome measure 
was used at initial assessment of patients during the InS:PIRE 
programme and at a 1-year follow-up review (14). This measure 
was initially developed for patients with pain related to cancer; 
however, it has since been used in a wide range of patient groups 
with chronic diseases and conditions, including fibromyalgia, 
neuromuscular pain and post-surgical pain (15–17). The con-
sensus panel Initiative on Methods, Measurement and Pain 
Assessment in Clinical Trials (IMMPACT) recommended that 
the 2 domains of the BPI be used in all chronic pain clinical 
trials (18). It allows patients to report their pain severity and 
interference with daily life. The BPI has been found to be a 
valid and reliable measure of chronic pain (19). 
On the BPI, patients record the severity of their pain over 
the previous 24 h, as worst, least, mean and current pain, on 
a 0–10-point numerical rating scale (where 0 = no pain and 
10 = worst pain imaginable). Developers of the tool recommend 
that all 4 items be used in a mean score (14). The optimal cut-
off points for pain severity using the BPI are as follows: 0 = no 
pain, 1–3 = mild pain, 4–6 = moderate pain, and 7–10 = severe 
pain (20–21). Pain interference is measured using 7 components 
to include: general activity, mood, walking ability, normal 
work, relations with other people, sleep and enjoyment of life. 
Interference has been recommended by the tool developers to 
be scored as a mean of the 7 items (14). At 12 months all items 
in this study were compared with baseline values.
Analgesics used by patients for pain prior to ICU admission 
and at initial clinic attendance were recorded by the pharma-
www.medicaljournals.se/jrm
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Incidence and location of pain
At baseline assessment, two-thirds (66%, n = 31) of 
patients reported a “new” chronic pain since ICU 
admission at initial assessment (Table I). In these 
patients, lower limb pain was reported in over two-
fifths of this group (42%, n = 13), but the shoulder joint 
was the most frequently affected joint (39%, n = 12), 
followed by the trunk/back (32%, n = 10), upper limb 
(6%, n = 2) and head (3%, n = 1) (Fig. 1). Thirty-nine 
percent of patients (n = 12) reporting a “new” chronic 
pain, had pain at more than one anatomical location/
joint. Bilateral symptoms were reported in almost all 
of those who reported having lower limb pain (85%, 
n = 11), in contrast to only one-third of those with 
shoulder pain (33%, n = 4).
Brief Pain Inventory intensity/severity
The mean BPI score for pain severity of those reporting 
a “new” chronic pain at initial assessment was 5.3 
(standard deviation (SD) 2.4; range 0–10) and the 
mean score at 1 year was 4.6 (SD 2.7). The difference 
between reported pain severity at baseline and at 1-year 
was not significant (p = 0.66). 
Brief Pain Inventory interference
The mean BPI score given by patients to describe the 
impact of pain on daily function or interference in 
those reporting chronic pain was 6.5 (SD 2.5). Pain 
interference decreased significantly between baseline 
assessment and follow-up at 1-year (mean 6.5 (SD 
2.5) vs mean 4.5 (SD 2.7), respectively) (p = 0.04). 
Further investigation of pain interference on individual 
activities of daily living indicated that “enjoyment of 
life” (mean 7.1, SD 2.8) and sleep (mean 6.9, SD 3.3) 
were the most severely affected and “relations” the 
least affected by chronic pain (mean 5.7, SD 3.5) at 
baseline assessment. However, at 1 year “enjoyment 
of life” (mean 5.2, SD 3.2) and “normal work” (mean 
5.2, SD 3.3) were the most affected. 
Predictors
There was no significant difference in any of the vari-
ables, including ICU length of stay (LOS) , age, SIMD 
or sepsis, between those with and without chronic pain 
(Table III).
Analgesics
The number of patients taking analgesics (steps 1–3 
pain medications, as defined by the WHO pain ladder) 
prior to admission was 43% (n = 20). This figure had 
increased to 81% (n = 38) at the time of the patients’ 
baseline clinic visit. The intensity of analgesics pres-
cribed also increased, with the number of patients 
prescribed strong opioids (step 3 of the WHO pain 
Table I. Patient demographics for the physiotherapy intervention group
Patient characteristics
Total number of participants 
(n = 47)
New chronic pain 
(n = 31)
No new chronic pain 
(n = 16)
Sex, male, % 68 55 81
Age, years, median (IQR) 52 (43–57) 51 (44–56) 54 (43–59)
Intensive care unit length of stay, days, median (IQR) 15 (10–27) 12 (7–27) 19 (11–29)
Acute Physiology and Chronic Health Evaluation, median (IQR) 23 (18–27) 23 (18–27) 23 (16–28)
Sepsis, yes, %a 64 58 75
Scottish Index of Multiple Deprivation decile, median (IQR)b 2 (1–4) 3 (1–4) 1 (1–4)
aSepsis as defined by the Surviving Sepsis Campaign (2013) (24). bScottish Index of Multiple Deprivation scores for 1–5, with 1 being the most deprived.
IQR: interquartile range.
Fig. 1. Anatomical location of “new” chronic pain at baseline assessment.
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joint 
Trunk/Back Upper limb Head 
Frequency (%) 
Table II. Admitting speciality
Admitting speciality n 
General medicine 19 
General surgery 12 
Gastroenterology 5 
Burns and plastics 4 
Orthopaedics 4 
Respiratory medicine 2
Urology 1
Table III. Risk factors for the incidence of chronic pain: results 
of binary logistic regression analysis
Variable p-value
Intensive care unit length of stay 0.53
Age 0.55
Scottish Index of Multiple Deprivation 0.29
Sepsis 0.09
J Rehabil Med 51, 2019
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ladder) increasing from 2% (n = 1) to 11% (n = 5). Even 
with the increase in the number and potency of pain 
medications prescribed, two-thirds of patients still 
reported a “new” chronic pain (Table IV).
Healthcare support
This study found that over a quarter of patients (26%, 
n = 8) were already accessing physiotherapy treatment 
prior to their initial InS:PIRE attendance and a further 
29% (n = 9) required referral after assessment to a spe-
cialist physiotherapist in areas such as the shoulder or 
back. A number of patients required referral to local 
gym schemes (19%, n = 6) to increase fitness and body 
strength, or onward referral to other services, such as 
their primary care physician (19%, n = 6). 
DISCUSSION
This is one of the first studies internationally to explore 
pain intensity and interference in ICU survivors. Two-
thirds of patients in this study reported a “new” chronic 
pain when attending an ICU follow-up programme. 
This chronic pain was of “moderate” intensity and was 
reported to be directly related to the ICU admission. 
The shoulder was the single most affected joint in this 
study, with almost two-fifths of patients reporting this 
problem. No significant predictors for chronic pain 
were found. Chronic pain resulted in a high level of 
interference in patients’ daily activities after discharge 
from the ICU, with “enjoyment of life” and “sleep” 
being the most severely affected at initial programme 
attendance. It was also found that patients who have 
had an ICU admission frequently needed pain medi-
cation for a “new” chronic pain after discharge from 
the ICU. Furthermore, there appeared to be a need for 
more potent analgesics following discharge from the 
ICU. Pain interference, but not pain severity, improved 
over the 1-year period, with “enjoyment of life” and 
“work” now being the most affected.
The incidence of chronic pain in this study is con-
sistent with a previous study in ICU survivors, which 
highlighted that up to 73% of patients reported chronic 
pain at 12 months post-ICU discharge (3). Similarly, 
another study reported that 56% of patients had chronic 
pain at 2 years post-discharge (25). This incidence of 
chronic pain is higher than the European population 
norm, which suggests that that 20% of people live with 
chronic pain (26). The incidence of shoulder pain in 
this study is almost double that of findings in another 
study which found that over 20% of patients had shoul-
der pain post-ICU (9). The shoulder is a vulnerable 
joint; the strategies employed to move patients in the 
ICU often depend on pressure being placed on this 
joint. This may be a cause of this new pain; however, 
more information and research in this area is required. 
The literature suggests that the causes of chronic pain 
post-ICU are multifactorial. The severity of patient’s 
illness in the ICU necessitates certain procedures, 
which often cause pain/discomfort and prolonged 
periods of immobilization, in addition to the critical 
illness process (7). No significant predictors for chronic 
pain were found in this population. However, ensuring 
early mobility and appropriate physical therapy within 
the hospital setting may help prevent some of the issues 
seen in this cohort of patients. At present the literature 
has focussed on functional capacity as an outcome 
measure for interventional rehabilitation research in 
this area. Future research must also understand the 
potential impact of these interventions for pain deve-
lopment in this group. 
In relation to the requirement for analgesics, there 
is a dearth of literature on the pharmacological mana-
gement of chronic pain in ICU survivors after hospital 
discharge and the associated cost. This is probably due 
to the lack of involvement of pharmacists in post-ICU 
follow-up clinics (27). It is important that future studies 
address this issue to ensure that patients are receiving 
safe, effective care. 
Strengths of this evaluation include its systematic 
approach to assessing pain in critically ill patients at-
tending an ICU recovery programme. Furthermore, 
this is one of the first studies to apply a standardized 
tool to help understand analgesic requirements in this 
population. However, this study has several limitations. 
Pain interference, but not pain severity, improved over 
time; this may be due to improved psychological status 
and the development of coping strategies to manage 
pain over time. It is unclear whether this improvement 
is correlated with self-efficacy and the amelioration of 
psychological problems, such as anxiety and depres-
sion. These data were not available for analysis in the 
present evaluation, but future research should explore 
psychological profiles with chronic pain. The definition 
of chronic pain utilized in this study, was pain which 
persisted for more 12 weeks. There are a number of 
different definitions of chronic pain in the literature 
and this may limited the scope of the findings of this 
study. Furthermore, this study took place in a single 
centre with a small population. ICU survivors are at 
Table IV. World Health Organization (WHO) pain ladder analgesic 
use on intensive care unit (ICU) admission and at initial assessment
WHO pain ladder level 
Patients at ICU 
admission 
n (%)
Patients at baseline 
clinic visit 
n (%)
No medication 27 (57) 9 (19)
Level 1 4 (9) 12 (25)
Level 2 15 (32) 21 (45)
Level 3 1 (2) 5 (11)
www.medicaljournals.se/jrm
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a high risk of developing chronic pain. This study did 
not have a pre-defined sample size and was a sample of 
convenience, thus may not have detected relationships 
between variables.
In conclusion, the findings of this small-scale quality 
improvement project suggest that post-ICU follow-up 
programmes should provide the appropriate support 
to manage chronic pain issues. Future large-scale, 
multi-site research related to post-ICU chronic pain is 
required to understand this problem further and to help 
design appropriate, effective interventions for patients.
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